SCHEMBL459101

SCHEMBL459101

O=C(O)C=Cc1ccc(Cc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 3/20 0.71
HDAC8 Q9BY41 3/20 0.67
HCAR2 Q8TDS4 2/20 0.67
HDAC3 O15379 2/20 0.67
HDAC1 Q13547 2/20 0.67
HDAC2 Q92769 2/20 0.67
TNKS O95271 1/20 0.67
HDAC4 P56524 1/20 0.67
HDAC7 Q8WUI4 1/20 0.67
HDAC10 Q969S8 1/20 0.67
HDAC11 Q96DB2 1/20 0.67
TNKS2 Q9H2K2 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
HDAC9 Q9UKV0 1/20 0.67
HDAC5 Q9UQL6 1/20 0.67
FFAR1 O14842 2/20 0.58
ESR1 P03372 2/20 0.57
ESR2 Q92731 2/20 0.57
CA12 O43570 2/20 0.57
AKR1B10 O60218 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772402 1.00 TBXAS1 (0.71) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL8921111 0.94 TBXAS1 (0.68) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL23854259 0.89 HDAC3 (0.67) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3225302 0.89 HDAC3 (0.67) TBXAS1HDAC8HCAR2HDAC3HDAC1
Bromide SCHEMBL1432660 0.85 TBXAS1 (0.56) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL4776134 0.85 TBXAS1 (0.55) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3105298 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3688787 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3105287 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL28357770 0.85 KDM4E (0.63) TBXAS1HDAC8HCAR2HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
EP-4302747-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2024-01-10 EP claimed
EP-2662434-B2 Use of specific compounds for enhancing odours SYMRISE AG (DE) 2023-08-16 EP claimed
US-20230121157-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2023-04-20 US claimed
EP-4117617-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2023-01-18 EP claimed
WO-2021219622-A1 HAND SANITISER COMPOSITION DSM IP ASSETS B.V. (NL) 2021-11-04 WO claimed
WO-2021180839-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2021-09-16 WO claimed
US-10920170-B2 Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether SYMRISE AG (DE) 2021-02-16 US claimed
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP claimed
EP-3423028-B1 METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS SYMRISE AG (DE) 2020-04-08 EP claimed
WO-2017207805-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2017-12-07 WO claimed
WO-2017207783-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2017-12-07 WO claimed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
EP-2859069-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT Ferrara, Marcello (IT) 2015-04-15 EP claimed
US-8999913-B2 Fragrance mixtures containing cyclopent-2-enyl ethyl acetate SYMRISE AG (DE) 2015-04-07 US claimed
WO-2013156228-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-24 WO claimed
US-20130270157-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-17 US claimed
US-20130172429-A1 FRAGRANCE MIXTURES CONTAINING CYCLOPENT-2-ENYL ETHYL ACETATE SYMRISE AG (DE) 2013-07-04 US claimed
EP-1417372-B1 FRAGRANCE COMPOSITIONS FOR CO2 DRY CLEANING PROCESS SYMRISE GMBH & CO KG (DE) 2006-09-27 EP claimed
US-6210816-B1 Translucent xerographic recording substrates XEROX CORPORATION 2001-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10920170-B2 Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether CCT8, F8, TRPM8 TBXAS1 444/4885HDAC8 1082/4885HCAR2 1862/4885
US-20230121157-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES CUTA, GLA, DPY30 TBXAS1 3585/4885HDAC8 671/4885HCAR2 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.